Department of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom.
Annu Rev Anal Chem (Palo Alto Calif). 2013;6:427-53. doi: 10.1146/annurev.anchem.111808.073648.
Continuous monitoring of clinical biomarkers offers the exciting possibility of new therapies that use biomarker levels to guide treatment in real time. This review explores recent progress toward this goal. We initially consider measurements in body fluids by a range of analytical methods. We then discuss direct tissue measurements performed by implanted sensors; sampling techniques, including microdialysis and ultrafiltration; and noninvasive methods. A future directions section considers analytical methods at the cusp of clinical use.
临床生物标志物的连续监测提供了一种令人兴奋的可能性,即可以使用生物标志物水平实时指导治疗的新疗法。本文探讨了实现这一目标的最新进展。我们首先考虑通过一系列分析方法在体液中进行的测量。然后,我们讨论了通过植入式传感器进行的直接组织测量;采样技术,包括微透析和超滤;以及非侵入性方法。未来方向部分考虑了处于临床应用边缘的分析方法。